Nutritional status and childhood wheezing in rural Bangladesh

Public Health Nutr. 2014 Jul;17(7):1570-7. doi: 10.1017/S1368980013001262. Epub 2013 May 17.

Abstract

Objective: To investigate the association between current childhood nutritional status and current wheezing among pre-school children in rural Bangladesh.

Design: Cross-sectional study.

Setting: Matlab region, rural Bangladesh.

Subjects: Children (n 912) aged 4·5 years. Anthropometric measurements of the mothers and their children were taken during a 1-year period from December 2007 to November 2008. Current wheezing was identified using the International Study of Asthma and Allergies in Childhood questionnaire. Serum total IgE was measured by human IgE quantitative ELISA. IgE specific antibody to dust mites (Dermatophagoides pteronyssinus) was measured by the CAP-FEIA system (Phadia AB, Uppsala, Sweden).

Results: Wheezing at 4·5 years old was significantly associated with stunting (OR = 1·58; 95 % CI 1·13, 2·22) and underweight (OR = 1·39; 95 % CI 1·00, 1·94). The association with stunting remained significant after adjustment for sex, birth weight, birth length, gestational age at birth, mother's parity, maternal BMI, family history of asthma, socio-economic status, season of birth and intervention trial arm (OR = 1·74; 95 % CI 1·19, 2·56).

Conclusions: Stunting was a significant risk factor for wheezing among rural Bangladeshi children. Further studies will be required to confirm the relationship between nutritional status and allergic illnesses in developing countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma / etiology*
  • Bangladesh
  • Child, Preschool
  • Cross-Sectional Studies
  • Developing Countries
  • Female
  • Growth Disorders / complications*
  • Humans
  • Immunoglobulin E / blood
  • Male
  • Malnutrition / complications*
  • Mites
  • Nutritional Status*
  • Odds Ratio
  • Respiratory Sounds*
  • Risk Factors
  • Rural Population
  • Surveys and Questionnaires
  • Thinness / complications*

Substances

  • Immunoglobulin E